Medicaid Generic Drug Price Fairness Act
Official title: A bill to extend the requirement that drug manufacturers that increase prices faster than inflation pay an additional rebate to State Medicaid programs to include manufacturers of generic drugs.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Medicaid Generic Drug Price Fairness Act - Amends title XIX (Medicaid) of the Social Security Act to extend to manufacturers of generic drugs the requirement that drug manufacturers in certain circumstances pay an additional rebate to state Medicaid programs.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2948: Medicaid Generic Drug Price Fairness Act. 113th Congress. Open America. https://openamerica.io/bill/113-S-2948/
"S. 2948: Medicaid Generic Drug Price Fairness Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-S-2948/.
S. 2948, 113th Cong. (2026), https://openamerica.io/bill/113-S-2948/.
[S. 2948: Medicaid Generic Drug Price Fairness Act](https://openamerica.io/bill/113-S-2948/)